Cribriform Breast Lesions Cribriform Lesions of the Breast Yunn-Yi - - PowerPoint PPT Presentation

cribriform breast lesions
SMART_READER_LITE
LIVE PREVIEW

Cribriform Breast Lesions Cribriform Lesions of the Breast Yunn-Yi - - PowerPoint PPT Presentation

5/26/2016 Cribriform Breast Lesions Cribriform Lesions of the Breast Yunn-Yi Chen, MD, PhD Professor Director of Immunohistochemistry Laboratory UCSF Uniform Cribriform Breast Lesions Cribriform Latin cribrum : sieve Medical


slide-1
SLIDE 1

5/26/2016 1 Cribriform Lesions of the Breast

Yunn-Yi Chen, MD, PhD Professor Director of Immunohistochemistry Laboratory UCSF

Cribriform Breast Lesions

Cribriform

Latin cribrum: sieve Medical definition: pierce with small holes Pathology: sieve-like histologic pattern, sheets of epithelial cells punctuated by (rounded) gland-like spaces

Uniform Cribriform Breast Lesions

slide-2
SLIDE 2

5/26/2016 2

Cribriform DCIS Invasive Cribriform Carcinoma Adenoid Cystic Carcinoma Collagenous Spherulosis

Cribriform Breast Lesions

Lobulocentric vs diffuse pattern Single vs dual cell populations Luminal contents IHC and molecular markers Myoepithelial cell (MEC) markers LMW CK, CK5/6 ER Other stains: CD117 (C-Kit), S100 FISH

Approach for Cribriform Lesions Cribriform DCIS-- Lobulocentric

Diagnostic accuracy of DCIS by pathologists

(Results of ECOG Trial 5194)

49/693 (7.1%): misclassified

(Simpson J, et al: USCAP meeting abstract, 2011, 64A)

ADH 28 (57%) UDH 5 (10%)

LCIS 5 Papilloma 2 Radial scar 2 Invasive carcinoma 3 Columnar cell lesion 2 Papillary apocrine change 1 Mucocele-like lesion 1

slide-3
SLIDE 3

5/26/2016 3

Distinction from ADH and UDH Criteria based on cytology, architecture and extent

  • Cytology-- monotonous, round to oval nuclei, distinct

cell membrane

  • Architecture-- rounder/rigid, polarized to lumen
  • Extent-- complete involvement of spaces, continuous

span > 2 mm (3 mm by some authors and arising in papilloma)

Inter-observer variability

  • Share with your colleagues

Adjunct: HMWK (CK5/6), ER

  • UDH-- CK5/6 positive (mosaic pattern), variable ER
  • ADH and DCIS– CK5/6 negative, diffuse and strong ER

Diagnosis of low grade Cribriform DCIS Cribriform DCIS UDH

Monotonous Evenly spaced Distinct cell membrane Nuclei polarized to lumen Heterogeneous Crowded and overlapping Indistinct cell membrane Nuclei lack of polarization

Cribriform DCIS UDH

Nuclei perpendicular to lumen Nuclei parallel to lumen

slide-4
SLIDE 4

5/26/2016 4 Usual Ductal Hyperplasia

CK5/6 ER

Atypical Ductal Hyperplasia--

Combined ER (brown) and CK5/6 (red) stain Negative CK5/6, diffuse and strong ER

Necrosis may be seen in UDH

slide-5
SLIDE 5

5/26/2016 5 UDH with necrosis

CK5/6 ER

Extent criteria for low-grade DCIS--

complete involvement of > 2 mm

2 mm

ADH ADH LG DCIS

CK5/6, p63 (brown)/LMW CK (red)

Benign Apocrine Proliferation

  • Apocrine cells are CK5/6 and ER negative
  • Uniform nuclei, fine chromatin
  • No necrosis

DCIS with apocrine features

  • Significant (≥3x) variation in nuclear size
  • Irregular nuclear membrane, coarse chromatin
  • Often with comedo necrosis
slide-6
SLIDE 6

5/26/2016 6

Cribriform DCIS Involving a Radial Sclerosing Lesion (RSL)

Cribriform DCIS in RSL-- Mimic invasion Reduced MEC staining p63 SMM

(Hilson et al: Am J Surg Pathol 2010;34:896-900)

Lobulocentric Single luminal type epithelial cells Luminal contents: calcifications Immunophenotype MEC around the duct space ER: +++ CAM5.2 +++, CK5/6 -

Cribriform DCIS

Benign Aggregates of eosinophilic fibrillar spherules or myxoid material (BM material) Biphasic myoepithelial and epithelial proliferation Two types of lumens

Collagenous Spherulosis

slide-7
SLIDE 7

5/26/2016 7

Collagenous Spherulosis: Lobulocentric

Collagenous Spherulosis Arising in a Papilloma

slide-8
SLIDE 8

5/26/2016 8

Coll IV SMM p63 Collagenous Spherulosis-- two cell populations

Myoepithelial cells pseudolumen Epithelial cells true glandular space

CAM5.2 SMM

Coll Spherulosis Cribriform DCIS

Collagenous Spherulosis-- Core Biopsy for Calcifications

slide-9
SLIDE 9

5/26/2016 9

Collagenous Spherulosis in Radial Scar

Monomorphic cells with cribriform architecture ? DCIS

slide-10
SLIDE 10

5/26/2016 10

LCIS involving collagenous spherulosis-- Pitfall in mimicking cribriform DCIS

E-cad E-cad p63

LCIS involving collagenous spherulosis-- positive E-cad staining from ME cells Lobulocentric Dual MEC and epithelial cells MEC: pseudolumens, BM material Epithelial cells: true glandular spaces, ± eosinophilic secretion Immunophenotype MEC markers + around pseudolumens LMW CK (CAM5.2) + around true glandular spaces

Collagenous Spherulosis

Invasive cribriform CA

Adenoid cystic CA

Invasive Carcinoma with Cribriform Pattern

slide-11
SLIDE 11

5/26/2016 11

Invasive Cribriform Carcinoma

Excellent prognosis Luminal A molecular type Cribriform pattern invading stroma Often mixed with other invasive (tubular carcinoma in 17-23%) Diagnosis--

> 90% cribriform pattern or >50% cribriform + tubular as the second component

Invasive Cribriform Carcinoma-- Diffuse

Inv cribriform CA-- irregular contours, desmoplastic stroma

Cribriform DCIS: Lobulocentric

slide-12
SLIDE 12

5/26/2016 12

DCIS: Smooth Contours, Myoepithelial Cells

Cribriform DCIS Inv Cribriform CA

Irregular contour Desmoplastic stroma

Inv cribriform CA-- smooth contours, mimic cribriform DCIS

p63

slide-13
SLIDE 13

5/26/2016 13

Smooth ME-like cells Invasive Irregular In situ p63 p63 SMM

Invasive and in situ cribriform carcinoma

Diffuse pattern Single luminal type epithelial cells Luminal contents: -/+ calcifications, mucin Immunophenotype MEC markers: - ER: +++ CAM5.2 +++; CK5/6 -

Invasive Cribriform Carcinoma

Invasive Cribriform CA Cribriform DCIS

Infiltrate between normal lobules and ducts Normal ductal and lobular architecture preserved Irregular, sharp, angulated edges Smooth, rounded contours Desmoplastic Normal stroma No myoepithelial cells Intact myoepithelial cells

slide-14
SLIDE 14

5/26/2016 14

Histology similar to salivary gland counterpart Various architectural patterns

  • Cribriform
  • Tubular/trabecular, solid/basaloid

Triple negative, basal-like molecular type

  • Lower mutation rate compared to TN IDC

t(6;9) MYB-NFIB translocation Favorable prognosis

Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma-- Diffuse

Adenoid Cystic CA

Adenoid Cystic CA

* * *

pseudolumen true lumen

Adenoid Cystic Carcinoma

slide-15
SLIDE 15

5/26/2016 15

* * * *

Adenoid Cystic Carcinoma Adenoid cystic carcinoma Epithelial-like Myoepithelial-like

Immunophenotype

biphasic differentiation

May demonstrate an “aberrant/variable” phenotype

Adenoid Cystic Carcinoma

p63 SMM CK7

Adenoid Cystic CA

slide-16
SLIDE 16

5/26/2016 16

Adenoid cystic carcinoma-- dual cell populations

Myoepithelial-like/basaloid cells: p63 +, calponin – (brown) Epithelial cells: CAM5.2 + (red)

breast triple stain

Diffuse pattern Dual cell types-- Myoepithelial-like/basaloid cells: pseudolumens with BM material Epithelial cells: true glandular spaces ± secretion Immunophenotype MEC markers: variable; usually p63 +, SMA +/- & SMM/calponin -/+ in basaloid cells LMW CK (CK7) + in epithelial cells ER/PR/HER2 -; CD117 & CK5/6 + (basal-like) MYB +

Adenoid Cystic Carcinoma

Adenoid Cystic Carcinoma

CK5/6 CD117 MYB

Adenoid Cystic Carcinoma--

Excellent Prognosis on population-based studies

Study Population Year # patients LN met Survival*

Ghabach

Surveillance, Epidemiology and End Results Program (SEER)

1977- 2006 338 14/335 (4.2%) 5 y RS: 98.1% 10 y RS: 94.9% 15 y RS: 91.4% Thompson

California Cancer Registry (CCR)

1988- 2006 244 12/244 (4.9%) 5 y RS: 95.6% 10 y RS: 94.9% Kulkarni

National Cancer Data Base

1998- 2008 933 36/703 (5.1%) 5 y OS: 88% (*RS: relative survival; OS: overall survival)

(Ghabach: Breast Cancer Res 2010; Thompson: Breast J 2011; Kulkarni: Ann Surg Oncol 2013)

slide-17
SLIDE 17

5/26/2016 17 56 y F with a breast lesion 56 y F with a breast lesion 56 y F with a breast lesion

Rare histologic subtype of breast cancer: 0.02% Originally as “Juvenile secretory carcinoma” in 1966

  • Most common childhood breast ca

Renamed “secretory carcinoma” in 1980s

  • ~2/3 pts > 50 y, mean age 53-56 (range 3 to 89)

Various growth patterns

  • Microcystic/cribriform
  • Papillary, solid, tubular

Secretory Carcinoma

slide-18
SLIDE 18

5/26/2016 18

Triple negative or low hormonal receptor expression, basal-like molecular type t(12;15) ETV6-NTRK3 translocation Favorable prognosis

  • Lower mutation rate than TN IDC
  • Simplex genomic profile by chromosomal analysis

Secretory Carcinoma Secretory Carcinoma-- Diffuse Secretory Carcinoma--

Abundant eosinophilic to amphophilic secretion

Secretory Carcinoma--

  • Abundant eosinophilic vacuolated cytoplasm
  • Medium-sized oval nuclei, small nucleoli; low mitotic activity
  • SBR grade 1 and 2
slide-19
SLIDE 19

5/26/2016 19 Secretory Carcinoma

PASD stain Secretory material: PASD and Alcian blue + S100 and mammaglobin +++ ER/PR/HER2 - or low ER/PR CK5/6 +

Secretory Carcinoma Secretory Carcinoma

S100 Stain Mammaglobin Stain

Secretory Carcinoma

ER CK5/6

  • ER/PR/HER2 – or low ER/PR
  • CK5/6 +
  • Basal-like
slide-20
SLIDE 20

5/26/2016 20 Secretory Carcinoma

  • Most microcystic/cribriform

glands are invasive

  • In situ component may be present

SMM SMM

Secretory Carcinoma--

t(12;15) with ETV6-NTRK3 gene fusion detected by ETV6 split apart FISH probe

ETV6 NTRK6

T(12;15)

Mammary secretory carcinoma Infantile fibrosarcoma Cellular congenital mesoblastic nephroma Some myeloid acute leukemia Mammary analogue secretory carcinoma (MASC) of the salivary gland Cutaneous MASC Some papillary thyroid carcinoma (?MASC of thyroid)

  • ~15% of PTC after radiation exposure, 1-4% of sporadic PTC
  • One case: TTF1/thyroglobulin - & mammaglobin/S100/GATA3 +

Tumors with ETV6-NTRK3 Translocation

Diffuse pattern Single cell type Extra- and intracellular secretory materials Immunophenotype MEC markers: - in invasive & + in in-situ components S100 and mammaglobin +++ ER/PR/HER2 - or low ER/PR; CK5/6 + (basal-like) t(12;15) with ETV6-NTRK3 fusion gene

Secretory Carcinoma

slide-21
SLIDE 21

5/26/2016 21

Secretory Carcinoma--

Favorable prognosis on population-based studies

Study Population Year # patients LN met Survival*

Horowitz

Surveillance, Epidemiology and End Results Program (SEER)

1983- 2007 83 29/83 (34.9%) 5 y CSS: 94.4% 10 y CSS: 91.4% (1 pt died of ca) Jacob

National Cancer Database

1998- 2011 246 66/206 (32.0%) OS better than IDC, median not reached (vs 14.8 years for IDC) (*CCS: cause-specific survival; OS: overall survival)

(Horowitz et al: The Breast 2012; Jacob et al: J Surg Oncol 2016)

Cribriform Lesions of the Breast

Yes No

? Pseudolumens with BM material, lined by p63/SMA + cells

Yes No ? Lobulocentric

Coll Spherulosis Cribriform DCIS Adenoid Cystic CA Inv Cribriform CA

SMM + SMM - MEC + MEC -

UDH and ADH Secretory CA

Cribriform Lesions: IHC

Collagenous Spherulosis Adenoid Cystic Invasive Cribriform Cribriform DCIS

SMM

Pos Neg Neg Pos

Calp

Pos Neg Neg Pos

p63

Pos Pos Neg Pos

SMA

Pos Pos Neg Pos

ER

Pos Neg Pos Pos

Crisi Am J Clin Pathol 2005;124:733 <> Mastropasqua Mod Pathol 2005;18:1277 Azoulay Mod Pathol 2005;18:1623 <> Rabban Mod Pathol 2006;19:1351 Foschini Semin Diagn Pathol 2010;27:77

Cribriform Breast Lesions

Inv cribriform CA Cribriform DCIS Adenoid cystic CA Coll spherulosis

p63 SMM

slide-22
SLIDE 22

5/26/2016 22

Cribriform Breast Lesions

Cribriform DCIS (> 2mm) LCIS in Coll. Spherulosis Secretory CA Inv Cribriform CA Adenoid Cystic CA UDH

Thank you!